These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19540359)

  • 1. Translational nanomedicine: status assessment and opportunities.
    Murday JS; Siegel RW; Stein J; Wright JF
    Nanomedicine; 2009 Sep; 5(3):251-73. PubMed ID: 19540359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges of clinical translation in nanomedicine: A qualitative study.
    Satalkar P; Elger BS; Hunziker P; Shaw D
    Nanomedicine; 2016 May; 12(4):893-900. PubMed ID: 26772431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine.
    Milane L; Amiji M
    Drug Deliv Transl Res; 2021 Aug; 11(4):1309-1315. PubMed ID: 33512669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging nanomedicine applications and manufacturing: progress and challenges.
    Sartain F; Greco F; Hill K; Rannard S; Owen A
    Nanomedicine (Lond); 2016 Mar; 11(6):577-80. PubMed ID: 26911307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurosurgery in the realm of 10(-9), Part 2: applications of nanotechnology to neurosurgery--present and future.
    Elder JB; Liu CY; Apuzzo ML
    Neurosurgery; 2008 Feb; 62(2):269-84; discussion 284-5. PubMed ID: 18382306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing the mindset in life sciences toward translation: a consensus.
    Duda GN; Grainger DW; Frisk ML; Bruckner-Tuderman L; Carr A; Dirnagl U; Einhäupl KM; Gottschalk S; Gruskin E; Huber C; June CH; Mooney DJ; Rietschel ET; Schütte G; Seeger W; Stevens MM; Urban R; Veldman A; Wess G; Volk HD
    Sci Transl Med; 2014 Nov; 6(264):264cm12. PubMed ID: 25429054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sound understanding of environmental, health and safety, clinical, and market aspects is imperative to clinical translation of nanomedicines.
    Rösslein M; Liptrott NJ; Owen A; Boisseau P; Wick P; Herrmann IK
    Nanotoxicology; 2017 Mar; 11(2):147-149. PubMed ID: 28055261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National Cancer Institute Alliance for nanotechnology in cancer-Catalyzing research and translation toward novel cancer diagnostics and therapeutics.
    Hartshorn CM; Russell LM; Grodzinski P
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Nov; 11(6):e1570. PubMed ID: 31257722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer nanomedicine: from drug delivery to imaging.
    Chow EK; Ho D
    Sci Transl Med; 2013 Dec; 5(216):216rv4. PubMed ID: 24353161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The History of Nanoscience and Nanotechnology: From Chemical-Physical Applications to Nanomedicine.
    Bayda S; Adeel M; Tuccinardi T; Cordani M; Rizzolio F
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31892180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticles in modern medicine: state of the art and future challenges.
    Murthy SK
    Int J Nanomedicine; 2007; 2(2):129-41. PubMed ID: 17722542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives and potential applications of nanomedicine in breast and prostate cancer.
    Liu Y; Solomon M; Achilefu S
    Med Res Rev; 2013 Jan; 33(1):3-32. PubMed ID: 23239045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nano/Microscale motors: biomedical opportunities and challenges.
    Wang J; Gao W
    ACS Nano; 2012 Jul; 6(7):5745-51. PubMed ID: 22770233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic and clinical proteomics from the EU Health Research perspective.
    Dyląg T; Jehenson P; van de Loo JW; Sanne JL
    Proteomics Clin Appl; 2010 Dec; 4(12):888-91. PubMed ID: 21179890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicine: reshaping clinical practice.
    Fadeel B; Kasemo B; Malmsten M; Strømme M
    J Intern Med; 2010 Jan; 267(1):2-8. PubMed ID: 20059640
    [No Abstract]   [Full Text] [Related]  

  • 16. From bench to bedside: successful translational nanomedicine: highlights of the Third Annual Meeting of the American Academy of Nanomedicine.
    Wei C; Liu N; Xu P; Heller M; Tomalia DA; Haynie DT; Chang EH; Wang K; Lee YS; Lyubchenko YL; Bawa R; Tian R; Hanes J; Pun S; Meiners JC; Guo P
    Nanomedicine; 2007 Dec; 3(4):322-31. PubMed ID: 18068093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Converging micro-nano-bio technologies towards integrated biomedical systems: state of the art and future perspectives under the EU-information & communication technologies program.
    Lymberis A
    Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():6-8. PubMed ID: 19162579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine applied to translational oncology: A future perspective on cancer treatment.
    Bregoli L; Movia D; Gavigan-Imedio JD; Lysaght J; Reynolds J; Prina-Mello A
    Nanomedicine; 2016 Jan; 12(1):81-103. PubMed ID: 26370707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmental air toxics: role in asthma occurrence?
    Larsen GL; Beskid C; Shirnamé-Moré L
    Environ Health Perspect; 2002 Aug; 110 Suppl 4(Suppl 4):501-4. PubMed ID: 12194880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translational Medicine is developing in China: a new venue for collaboration.
    Wang X; Wang E; Marincola FM
    J Transl Med; 2011 Jan; 9():3. PubMed ID: 21205297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.